Skip to main content

Table 2 Best-corrected visual acuity (BCVA) during the course of the study for each of the groups

From: Visual outcome of various dose of glucocorticoids treatment in nonarteritic anterior ischemic optic neuropathy– a retrospective analysis

 

Time

 

Total

Groups

P value

Group1

Group2

Group3

Group4

BCVA

Baseline

Value

0.70

(0.28–1.22)

0.52

(0.15–1.70)

0.76

(0.43–1.17)

0.7

(0.22–1.00)

0.82

(0.54–1.40)

0.495*

7–14 day follow-up (day)

Value

0.40

(0.22–0.82)

0.52

(0.97–1.40)

0.61

(0.24–0.96)

0.40

(0.19–0.82)

0.35

(0.30–1.07)

0.936*

Change

0.125

(0.000–0.398)

0.000

(0.000–0.125)

0.102

(0.000–0.242)

0.088

(0.000–0.253)

0.213

(0.104–0.511)

0.035*

P-within

 

0.635

0.008

0.009

< 0.001

 

Final follow-up (day)

Value

0.46

(0.15–0.82)

0.52

(0.97–1.00)

0.46

(0.19–0.90)

0.52

(0.14–0.73)

0.4

(0.17–0.96)

0.974*

Change

0.125

(0.000–0.398)

0.058

(−0.058 to 0.301)

0.161

(0.836–0.281)

0.088

(−0.097 to 0.398)

0.349

(0.000–0.595)

0.277*

P-within

 

0.31#

0.012

0.03#

0.009#

 
  1. *Based on Kruskal-Wallis test
  2. †Based on paired student’s t-test
  3. #Based on Mann-Whitney U Test